The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
18F-fluoro-2-deoxy-glucose positron emission tomography/computed tomography evaluation to predict postoperative outcomes for patient with luminal-type breast cancer.
Kenjiro Aogi
No relevant relationships to disclose
Sachiko Kiyoto
No relevant relationships to disclose
Yoshifumi Sugawara
No relevant relationships to disclose
Takayuki Kadoya
No relevant relationships to disclose
Hideo Shigematsu
No relevant relationships to disclose
Norio Masumoto
No relevant relationships to disclose
Morihito Okada
No relevant relationships to disclose